Form 4 for CRL Charles River Laboratories
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-22 · accession 0001127602-24-006706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-02-23 | 2024-02-22 | CRL | Barbo William D | CCO, Corp. Executive VP | S - Sale | $248.50 | -4,050 | 22.9K | -15% | -$1.01M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | S | D | 4,050 | $248.50 | 22,879 | I By Trust | — | — | (F1) Reflects the exempt transfer pursuant to Rule 16a-13 of 7,547 shares held by the reporting person to William D. Barbo Revocable Trust. |